Success Metrics

Clinical Success Rate

100.0%

Based on 9 completed trials

Completion Rate

100%(9/9)

Active Trials

2(13%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

60%

Ph phase_3

13%

Ph phase_2

13%

Ph phase_4

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution14 total trials

Phase 2Efficacy & side effects

2(14.3%)

Phase 3Large-scale testing

2(14.3%)

Phase 4Post-market surveillance

1(7.1%)

N/ANon-phased studies

9(64.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(9)

Terminated(1)

Other(2)

Detailed Status

Completed9

Recruiting2

unknown2

Not yet recruiting1

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 22 (14.3%)

Phase 32 (14.3%)

Phase 41 (7.1%)

N/A9 (64.3%)

Trials by Status

not_yet_recruiting17%

completed960%

recruiting213%

withdrawn17%

unknown213%

Recent Activity

2 active trials

Showing 5 of 15

withdrawn

RELISTOR's Effects on Opioid-Induced Constipation

NCT04930237

not_yet_recruitingnot_applicable

The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With Transverse Maxillary Deficiency (TMD)

NCT07309640

recruitingphase_3

Better Evidence and Translation for Calciphylaxis

NCT05018221

completednot_applicable

The Exploration of the Regulatory Effect of Magnesium on Intestinal Flora in Healthy Adults

NCT05597150

recruitingphase_2

Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

NCT06321796

View all 15 trials

Clinical Trials (15)

Showing 15 of 15 trials

NCT04930237

RELISTOR's Effects on Opioid-Induced Constipation

Withdrawn

NCT07309640Not Applicable

The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With Transverse Maxillary Deficiency (TMD)

Not Yet Recruiting

NCT05018221Phase 3

Better Evidence and Translation for Calciphylaxis

Recruiting

NCT05597150Not Applicable

The Exploration of the Regulatory Effect of Magnesium on Intestinal Flora in Healthy Adults

Completed

NCT06321796Phase 2

Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders

Recruiting

NCT04462796Not Applicable

The Effect of Magnesium Citrate Supplementation in Restless Legs Syndrome (RLS)

Unknown

NCT03716609Not Applicable

Effects of Magnesium Supplementation on Hemodynamic Parameters and Cognitive Function

Completed

NCT03824379Phase 2

Magnesium Supplementation in Diabetic Nephropathy

Completed

NCT02032186Phase 3

A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy

Completed

NCT02690012Not Applicable

Feasibility of Using an Integrated Consent Model to Compare Two Standard of Care Regimens for the Management of Hypomagnesemia From Anti-Cancer Therapies

Completed

NCT03002545Not Applicable

Magnesium Supplementation in Type II Diabetes

Completed

NCT03632590Not Applicable

Magnesium and Vascular Stiffness

Unknown

NCT02235805Not Applicable

Magnesium and Vascular Stiffness

Completed

NCT01510665Not Applicable

Magnesium Supplementation in the Second Trimester of Pregnancy to Overweight and Obese Individuals